Virtu KCG Holdings’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-11,566
Closed -$7K 4108
2016
Q3
$7K Sell
11,566
-3,578
-24% -$2.42K ﹤0.01% 2994
2016
Q2
$11K Buy
+15,144
New +$10.7K ﹤0.01% 2842

Other funds holding MATN

Virtu KCG Holdings's MATN Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 11,566 shares — an estimated $7K sold.

Virtu KCG Holdings first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $11K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 11,566 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $7K.
  • Virtu KCG Holdings first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Virtu KCG Holdings's Mateon Therapeutics, Inc. position peaked at $11K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.